Comparing two PFO closure devices for stroke prevention
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial compares two devices used to close a hole in the heart (called a PFO) in adults who have had a stroke or mini-stroke (TIA) within the last year. The goal is to see which device works better to prevent future strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 64 years old
- Had a stroke or mini-stroke (TIA) in the past 12 months with no other clear cause
- Have a PFO (a small hole in the heart) that allows blood to flow from right to left
- Your doctor confirms the PFO can be closed with one of the two study devices
- You agree to return for follow-up visits as required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device to close a PFO (a small hole in the heart) in people who have had a stroke caused by a blood clot passing through that hole. The goal is to see if the device can prevent another stroke.
This trial tests whether closing a hole in the heart (a PFO) with a special device can help prevent another stroke after an unexplained stroke. You may be a candidate if your stroke likely happened because blood can pass through this PFO.
This trial tests a new device to close a PFO (a small hole between the upper chambers of the heart) in people who have had a stroke caused by a blood clot. The goal is to prevent future strokes by blocking the hole.
This trial looks at the safety and results of closing a PFO (a small hole in the heart) in people who have had a stroke or embolism with no other clear cause. If you qualify, doctors will close your PFO using a small tube inserted through a blood vessel and then follow your health over time.
This study looks at whether treating a history of “cryptogenic” stroke (stroke with no clear cause) using a patent foramen ovale (PFO) closure, plus medical therapy, is better than medical therapy alone. It focuses on people over 60 with a heart shunt seen on an ultrasound of the heart.
This study looks at whether closing a heart opening called a patent foramen ovale (PFO) with a special septal occluder, along with antiplatelet medications, can lower the risk of another stroke. It is for people who recently had a stroke thought to be caused by a clot that traveled from the heart but without another clear source.
Hear when a new Patent Foramen Ovale trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.